A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

December 29, 2021

Study Completion Date

December 29, 2021

Conditions

Healthy

Interventions

DRUG

Lu AG06466 Capsule

Hard capsule

DRUG

Lu AG06466 Tablet

Film-coated tablet

DRUG

Antacid

Oral suspension

Trial Locations (1)

LabCorp Clinical Research Unit Ltd, Leeds

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT05028673 - A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants | Biotech Hunter | Biotech Hunter